The effectiveness of dexmedetomidine infusion for sedating oral cancer patients undergoing awake fibreoptic nasal intubation

European Journal of Anaesthesiology

Volumn 27, Issue 1, 2010, Pages 36-40

  Chua, Koung Shing ^b,c   Wang, Fu Yuan ^a   Hsu, Hung Te ^a   Lua, I Cheng ^b   Wang, Hsun Mo ^d   Tsai, Cheng Jing ^a,d  

^a Department of Anesthesiology ^*  (United States)

^b Graduate Institute of Medicine   (United States)

^c Department of Surgery   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Dexmedetomidine; Fibreoptic nasal intubation; Oral cancer

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; HYPNOTIC SEDATIVE AGENT; INTRAVENOUS ANESTHETIC AGENT;

ADULT; AIRWAY OBSTRUCTION; AMNESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUS SEDATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ELECTIVE SURGERY; FEMALE; FIBERSCOPE ENDOSCOPY; HEMODYNAMIC PARAMETERS; HUMAN; MALE; MOUTH CANCER; NASOTRACHEAL INTUBATION; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; TIME; AGED; FIBER OPTICS; INTRAVENOUS DRUG ADMINISTRATION; INTUBATION; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR;

ADULT; AGED; AMNESIA; ANESTHETICS, INTRAVENOUS; CONSCIOUS SEDATION; DEXMEDETOMIDINE; FEMALE; FENTANYL; FIBER OPTIC TECHNOLOGY; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTUBATION; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PATIENT SATISFACTION;

EID: 76649115274     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832e0d2b     Document Type: Article

References (20)

1. Rai MR, Parry TM, Dombrovskis A, Warner OJ. Remifentanil targetcontrolled infusion vs propofol target-controlled infusion for conscious sedation for awake fibreoptic intubation: a double-blinded randomized controlled trial. Br J Anaesth 2008; 100:125-130.
2. Bergese SD, Khabiri B, Roberts WD, et al. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 2007; 19:141-144.
3. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 2007; 19:370-373.
4. Belleville JP, Ward DS, Bloor BC, Maze M. Effects of intravenous dexmedetomidine in humans. I: sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77:1125-1133.
5. Stricker P, Fiadjoe JE, McGinnis S. Intubation of an infant with Pierre Robin sequence under dexmedetomidine sedation using the Shikani Optical Stylet. Acta Anaesthesiol Scand 2008; 52:866-867.
6. Maroof M, Khan RM, Jain D, Ashraf M. Dexmedetomidine is a useful adjunct for awake intubation. Can J Anaesth 2005; 52:776-777.
7. Avitsian R, Lin J, Lotto M, Ebrahim Z. Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: a clinical series. J Neurosurg Anesth 2005; 17:97-99.
8. Grant SA, Breslin DS, MacLeod DB, et al. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 2004; 16:124-126.
9. Stamenkovic DM, Hassid M. Dexmedetomidine for fiberoptic intubation of a patient with severe mental retardation and atlantoaxial instability. Acta Anaesthesiol Scand 2006; 50:1314-1315.
10. Jooste EH, Ohkawa S, Sun LS. Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingements [letter to the editor]. Anesth Analg 2005; 101:1248.
11. Scher CS, Gitlin MC. Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anaesth 2003; 50:607-610.
12. Jaakola ML, Ali-Melkkila T, Kanto J, et al. Dexmedetomidine reduces intraocular pressure, intubation responses and anaesthetic requirements in patients undergoing ophthalmic surgery. Br J Anaesth 1992; 68: 570-575.
13. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54:1136-1142.
14. Knolle E, Oehmke MJ, Gustorff B, et al. Target-controlled infusion of propofol for fibreoptic intubation. Eur J Anaesthesiol 2003; 20:565-569.
15. Puchner W, Egger P, Puhringer F, et al. Evaluation of remifentanil as single drug for awake fiberoptic intubation. Acta Anaesthesiol Scand 2002; 46:350-354.
16. Lallo A, Billard V, Bourgain JL. A comparison of propofol and remifentanil target-controlled infusions to facilitate fiberoptic nasotracheal intubation. Anesth Analg 2009; 108:852-857.
17. Machata AM, Gonano C, Holzer A, et al. Awake nasotracheal fiberoptic intubation: patient comfort, intubating conditions, and hemodynamic stability during conscious sedation with remifentanil. Anesth Analg 2003; 97:904-908.
18. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394.
19. Lawrence CJ, De Lange S. Effects of a single preoperative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia 1997; 52:736-744.
20. Aantaa R, Kanto J, Scheinin M, et al. Dexmedetomidine, an alpha 2-adrenoceptor agonist, reduces anesthetic requirements for patients undergoing minor gynecologic surgery. Anesthesiology 1990; 73:230-235.